Mr. DiLaura is a life sciences executive based in San Francisco and he currently advises a number of biotechnology and pharmaceutical companies and investors. Formerly, he was CEO of Second Genome, a pioneering microbiome therapeutics company, from seed financing through clinical development. Previously, Mr. DiLaura held a range of executive roles in the systems biology company Ingenuity Systems (Qiagen), with responsibility for commercial operations, sales and marketing, product strategy, and corporate development. He was also a Consultant at The Wilkerson Group, providing strategic consulting to biotech, pharma, medical device, and diagnostic companies and investors. He holds a BS in economics from The Wharton School at the University of Pennsylvania.